The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

Atrial fibrillation (AF) is the most common clinically relevant arrhythmia and is associated
with increased morbidity and mortality. The incidence of AF is expected to continue to rise …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted, focusing on 2006 through October 2012 and …

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. It can occur at any
age but is very rare in children and becomes extremely common in the elderly, with a …

The natural history of atrial fibrillation (AF) is characterized by a gradual worsening with time.
The recent finding that AF itself produces changes in atrial function and structure has …

The term atrial cardiomyopathy, which has been used sporadically in the medical literature,
was recently the subject of a detailed Consensus Document prepared by representatives of …

Atrial fibrillation is a condition in which control of heart rhythm is taken away from the normal
sinus node pacemaker by rapid activity in different areas within the upper chambers (atria) of …

Background Atrial fibrillation (AF) may persist due to structural changes in the atria that are
promoted by inflammation. C-reactive protein (CRP), a marker of systemic inflammation …

Rhythmic and effective cardiac contraction depends on appropriately timed generation and
spread of cardiac electrical activity. The basic cellular unit of such activity is the action …

Rapid advancements in cardiac electrophysiology require today's health care scientists and
practitioners to stay up to date with new information both at the bench and at the bedside …